Multiple Myeloma is an incurable blood cancer with high relapse rates, prompting the need for novel immunotherapies. Researchers have developed an interactive tool based on a single-cell RNA-sequencing atlas of the MM immune microenvironment to guide the development of new treatments. The tool focuses on understanding the tumor-immune microenvironment to overcome resistance mechanisms in MM therapy. The study revealed changes in immune populations during disease progression, highlighting the potential of immune-boosting therapies. The tool is freely accessible and can aid in patient stratification and the development of durable immunotherapeutic strategies in Multiple Myeloma.
Source link
Interactive atlas unveils immune changes in multiple myeloma
